Mersana Therapeutics (MRSN) Stock: Buy, Sell, or Hold?
MRSN - Mersana Therapeutics, Inc. Common Stock
$29.08
0.04 (0.14%)
â˛
5d:
+0.02%
30d:
+5.1%
90d:
+251.21%
WAIT
LOW Confidence
Analysis Updated: Jan 5, 2026 12:00 AM ET
Get Alerted When MRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MRSN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MRSN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MRSN is currently trading at $29.08, which is considered fair based on recent price action.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading below Wall St target ($33.20)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$28.11
Resistance Level
$30.39
Current Trend
Strong Uptrend
Technical data as of
Jan 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$33.20
(+14.2%)
Revenue Growth (YoY)
-12.6%
Profit Margin
-211.2%
Share & Embed Analysis
Last updated: September 07, 2026 6:30 AM ET
Data refreshes hourly during market hours. Next update: 7:30 AM
Data refreshes hourly during market hours. Next update: 7:30 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 45 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 64 BUY |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 57 HOLD |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 35 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 51 HOLD |
